Literature DB >> 23798809

Calretinin immunohistochemistry: A new cost-effective and easy method for diagnosis of Hirschsprung's disease.

Lavanya Kannaiyan1, Sujani Madabhushi, Ramani Malleboyina, Narendra Kumar Are, K Ramesh Reddy, Bhuvaneshwar Rao.   

Abstract

AIM: To evaluate the efficacy of calretinin immunostaining in diagnosing Hirschsprung's disease (HD).
MATERIALS AND METHODS: Sixty cases were studied over a period of 1 year (July 2010-June 2011). There were 36 full-thickness biopsies and 24 resected specimens. Calretinin processing was done on the paraffin-embedded blocks after routine histopathological examination.
RESULTS: Of the 36 biopsy specimens, in 19 cases HD was diagnosed by hematoxylin and eosin (H and E) staining earlier. In 2 patients, ganglion cells were seen and HD was ruled out. In 15 cases, there was a diagnostic dilemma and calretinin was used. Ganglion cells were found in 3 specimens and nerve fibers in 5. In all 24 resected specimens, calretinin correlated with the findings on H and E staining.
CONCLUSIONS: Calretinin was extremely useful in solving the suspicious and indeterminate cases of HD. It can serve as a valuable cost-effective diagnostic aid in the centers where acetylcholinesterase enzyme histochemistry is not available.

Entities:  

Keywords:  Hirschsprung's disease; calretinin; immunohistochemistry

Year:  2013        PMID: 23798809      PMCID: PMC3687149          DOI: 10.4103/0971-9261.109355

Source DB:  PubMed          Journal:  J Indian Assoc Pediatr Surg        ISSN: 0971-9261


INTRODUCTION

The diagnosis and extent of resection in the management of HD depend on the sensitive and specific identification of ganglion cells.[1-3] However, documenting aganglionosis is often difficult and tedious on routine hematoxylin-eosin (H and E) stained sections. Acetylcholinesterase (AChE) has evolved as the gold standard in diagnosing HD; however, this histochemical analysis is technically challenging, and to date, has not gained worldwide utilization and applicability.[4] The aim of this study was to evaluate the efficacy of calretinin immunostaining[57] in the ganglionic and aganglionic HD colon biopsy specimens and correlate with the H and E, thereby exploring its utility in suspicious cases of HD.

MATERIALS AND METHODS

Our standard protocol of care for a child presenting with HD is barium enema study at presentation followed by a laparotomy where multiple biopsies are taken from the spastic aganglionic segment, transition zone, and the normal colon. A colostomy is sited at the level of the junction between the normal colon and the transition zone. The definitive surgery of choice is Duhamel's pull-through after 6 months of age. This was a prospective study from June 2010 to June 2011. Specimens from 60 patients with HD were evaluated. Thirty-six were full-thickness rectal biopsies (for suspected HD) and 24 were bowel segments resected during the definitive pull-through surgery. Calretinin (monoclonal mouse antihuman antibody (DAKO), (CLONE: DAK–calret 1, Code: IR627) immunohistochemistry (IHC) staining was done on all paraffin-embedded blocks after routine H and E examination.

RESULTS

The age of patients ranged from 1 day to 14 years (mean 8.2 months), and there were 46 boys and 14 girls (M:F = 3.2-3.3:1; normal ratio 3:1-4:1). Twenty-three patients (63.8%) presented at less than 1 month of age. Seven (19.5%) patients presented between 1 month and 1 year of age. Six (16.7%) patients presented after the age of 1. Forty-nine patients had classical segment disease (81.7%). Five (8.3%) had long segment disease, 6 (10%) had total colonic aganglionosis. During the analysis of 36 initial full-thickness colon biopsy specimens, H and E staining revealed absence of ganglion cells (negative) in 19 cases (52.7%), presence of ganglion cells (positive) in 2 cases (0.05%), and suspected presence of ganglion cells in 15 cases (41.6%). Of the 19 cases reported negative through H and E staining, 17 (47.22%) were reported negative, and 2 (0.05%) positive for calretinin histochemistry for the ganglion cells and nerve fibers [Table 1].
Table 1

Hematoxylin and eosin staining versus calretinin in rectal biopsies

Hematoxylin and eosin staining versus calretinin in rectal biopsies In 15 patients, the H and E sections were suspicious of a presence of ganglion cell. Calretinin IHC showed immunopositivity in 3 slides, whereas 5 slides showed immunopositivity in nerve fibers. Among the 5 slides positive for nerve fibers, in 2 of the cases (2/60), calretinin gave a slight positive staining of nerve fibers, but with no staining of other areas. Later, surgery revealed an ultrashort segment HD with only 1 cm of aganglionosis. The slight calretinin positivity in the 2 specimens was observed in some large bundles with no staining in other areas, and thus indicating the beginning of transition zone. In the 24 patients where resected specimens from the definitive surgery were sent, serial biopsies were taken from the aganglionic segment, transition zone, and the ganglionic segment [Table 2]. Calretinin was not expressed in the ganglion cells and nerve fibers of submucosal and myenteric plexus of 24 aganglionic (spastic) segments. In the transition zone, calretinin staining was positive in the ganglion cells in 20 cases (83.3%) and was focally positive in the nerve fibers of 22 cases (91.6%), both in the submucosal and myenteric plexus. In ganglionic bowel segments of HD, calretinin showed immunopositivity in > 90% of ganglion cells and nerve fibers of submucosal and myenteric plexus.
Table 2

Calretinin staining in aganglionic, transition and ganglionic zone of resected specimens

Calretinin staining in aganglionic, transition and ganglionic zone of resected specimens

DISCUSSION

The histological diagnosis of HD is challenging, requiring the expertise of a senior pathologist and access to specialized techniques for handling frozen specimens for AChE staining.[458] This makes the diagnosis of HD difficult in centers where cases are infrequent, causing a delay in the treatment of the child. Calretinin is proven to be highly sensitive for the presence of ganglion cells and nerve fibers.[67] This protein is involved in calcium transport; and its absence allows accumulation of cytoplasmic calcium, causing excess neuroexcitability and ultimate neurodegeneration. Barshack, et al.,[7] procured the colons of 10 patients with proven HD. Calretinin IHC was performed on sections from the aganglionic zone, ganglionic zone, and transition zone of these colons. They identified calretinin staining in interstitial nerve fibres (INF) and ganglion cells in normal colon [Figures 1 and 2] and focal INF staining in 92% of transition zones. In contrast, there was no INF or ganglion cell staining in the aganglionic zone. It is easily applied to paraffin-embedded specimens. It can be interpreted as positive or negative for immune reactivity reducing the ambiguity in diagnosis. In our study, in the rectal biopsy specimens, diagnosis was ambiguous in 15 patients on H and E examination. By using calretinin, immune positivity was demonstrated in 3 patients (3 for ganglion cells and 5 for nerve fibers); thereby, ruling out HD in these patients.
Figure 1

Hematoxylin and eosin section with ganglion cell (arrow) (H and E, 10×)

Figure 2

Calretinin staining of ganglion cells (H and E, 40×)

Hematoxylin and eosin section with ganglion cell (arrow) (H and E, 10×) Calretinin staining of ganglion cells (H and E, 40×) Guinard-Samuel, et al.,[5] have studied the largest number of suction biopsies using calretinin. They have concluded that calretinin is accurate in proving the absence of ganglion cells, it is easy to interpret, and can replace AChE to diagnose HD. They, however, recommend that it should be used as an aid along with H and E examination, especially in ultrashort segment disease and transition zone specimens. In our study, we found that calretinin correlated with H and E examination in both rectal biopsies and the resected bowel specimens. In the rectal biopsy specimens, calretinin also aided in the diagnosis of 15 patients with ambiguous findings.

CONCLUSIONS

Calretinin IHC is accurate in detecting the presence or absence of ganglion cells and holds several advantages such as follows: (1) It can be carried out on paraffin-embedded tissue sections; (2) Staining pattern is simple; (3) Binary pattern of interpretation (negative or positive); (4) It is cost effective. In the present study, we found calretinin extremely useful in solving the doubtful cases of HD. It can serve as a valuable cost-effective diagnostic aid in the centers where AChE enzyme histochemistry is not available.
  8 in total

1.  Legacy of Harald Hirschsprung.

Authors:  V Jay
Journal:  Pediatr Dev Pathol       Date:  2001 Mar-Apr

2.  Hirschsprung's disease; a new concept of the etiology; operative results in 34 patients.

Authors:  O SWENSON; H F RHEINLANDER; I DIAMOND
Journal:  N Engl J Med       Date:  1949-10-13       Impact factor: 91.245

3.  Calretinin immunostaining as an adjunct in the diagnosis of Hirschsprung disease.

Authors:  Susan K Holland; Preetha Ramalingam; Robert H Podolsky; Michelle D Reid-Nicholson; Jeffrey R Lee
Journal:  Ann Diagn Pathol       Date:  2011-06-08       Impact factor: 2.090

Review 4.  Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child.

Authors:  Roshni Dasgupta; Jacob C Langer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-01       Impact factor: 2.839

5.  Calretinin immunohistochemistry versus acetylcholinesterase histochemistry in the evaluation of suction rectal biopsies for Hirschsprung Disease.

Authors:  Raj P Kapur; Robyn C Reed; Laura S Finn; Kathleen Patterson; Judy Johanson; Joe C Rutledge
Journal:  Pediatr Dev Pathol       Date:  2009 Jan-Feb

6.  The loss of calretinin expression indicates aganglionosis in Hirschsprung's disease.

Authors:  I Barshack; E Fridman; I Goldberg; Y Chowers; J Kopolovic
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

7.  Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung disease.

Authors:  Vincent Guinard-Samuel; Arnaud Bonnard; Pascal De Lagausie; Pascale Philippe-Chomette; Corine Alberti; Alaa El Ghoneimi; Michel Peuchmaur; Dominique Berrebi-Binczak
Journal:  Mod Pathol       Date:  2009-07-31       Impact factor: 7.842

8.  Calretinin immunohistochemistry in Hirschsprung's disease: An adjunct to formalin-based diagnosis.

Authors:  Ayper Kaçar; Ata Türker Arikök; Müjdem Nur Azili; Günay Ekberli Ağirbaş; Tuğrul Tiryaki
Journal:  Turk J Gastroenterol       Date:  2012-06       Impact factor: 1.852

  8 in total
  6 in total

1.  Expression profiles of HA117 and its neighboring gene DPF3 in different colon segments of Hirschsprung's disease.

Authors:  Hang Liu; Yuanyuan Luo; Shuangshuang Li; Shiqi Wang; Ning Wang; Xianqing Jin
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Abundance and significance of neuroligin-1 and glutamate in Hirschsprung's disease.

Authors:  Jian Wang; Hao Du; Ya-Ru Mou; Jian-Yi Niu; Wen-Tong Zhang; Hong-Chao Yang; Ai-Wu Li
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

3.  A variant pattern of calretinin immunohistochemistry on rectal suction-biopsies is fully specific of short-segment Hirschsprung's disease.

Authors:  Vincent Guinard-Samuel; Arnaud Bonnard; Michel Peuchmaur; Dominique Berrebi
Journal:  Pediatr Surg Int       Date:  2014-06-20       Impact factor: 1.827

4.  Evaluation of Calretinin as a New Marker in the Diagnosis of Hirschsprung Disease.

Authors:  Mohammad Hossein Anbardar; Bita Geramizadeh; Hamid Reza Foroutan
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

5.  A study on genetic polymorphism of RET proto-oncogene in Hirschsprung's disease in children.

Authors:  Madhu Kumari; Chhanda Das; Madhumita Mukhopadhyay; Rishav Dev Patra; Pradip Kumar Mitra; Biswanath Mukhopadhyay
Journal:  Afr J Paediatr Surg       Date:  2020 Jul-Dec

6.  Calretinin immunohistochemical staining in Hirschsprung's disease: An institutional experience.

Authors:  Ebru Zemheri; Pinar Engin Zerk; Cigdem Ulukaya Durakbasa
Journal:  North Clin Istanb       Date:  2021-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.